Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Histatin Stimulates Proliferation in Human Primary Corneal Endothelial Cells

Ramkumar Srinivasagan; Patrick Hughes; James Burke; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4143.

ARVO Annual Meeting Abstract June 2024

Optimization of Next-Generation α-Crystallin Chaperones (αCC) for the Treatment of Dysfunctional Lens Syndrome

Patrick Hughes; James A Burke; Rozemarijn S Verhoeven; Ricardo Cruz; Dell Larned; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5031.

ARVO Annual Meeting Abstract June 2023

Histatin-1 Decreases Corneal Endothelial Cell Death in Ex-Vivo Human Corneas

Onkar Sawant; Jessica Ludwig; Madison Castellanos; Dixie-Lee Shurland; Matt Chang; Ricardo Cruz; Patrick Hughes; James A Burke; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):617.

ARVO Annual Meeting Abstract June 2023

Next-Generation α-Crystallin Chaperones for the Treatment of Dysfunctional Lens Syndrome.

Patrick Hughes; James A Burke; Rozemarijn S Verhoeven; Dell Larned; Ricardo Cruz; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1224.

ARVO Annual Meeting Abstract June 2023

Intravitreal α-Crystallin Chaperone Reverses Lens Opalescence in Non-Human Primates with Spontaneous Cataracts

James A Burke; Patrick Hughes; Rozemarijn S Verhoeven; Dell Larned; Sanjay R Kedhar; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2466.

ARVO Annual Meeting Abstract June 2022

Histatin Improves Corneal Wound Healing in a Rabbit Model of Surgical Keratectomy

James Burke; Rozemarijn S Verhoeven; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1120.

ARVO Annual Meeting Abstract June 2022

Nonclinical Pharmacokinetics and Pharmacodynamics of Brimochol, a Combination Product for the Treatment of Presbyopia

Rozemarijn S Verhoeven; James Burke; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1819 – F0435.

ARVO Annual Meeting Abstract June 2017

In vitro Sustained Release of Tyrosine Kinase Inhibitors from Biodegradable PRINT Implants

Melissa Sandahl; Kwadwo Caesar; Janet Tully; Mari Yang; Stuart Williams; Rhett M Schiffman; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4458.

ARVO Annual Meeting Abstract June 2017

In vitro and In vivo Sustained Release of Dexamethasone from Intravitreal Implants

Janet Tully; Mari Yang; Stuart Williams; Sanjib Das; Rozemarijn S Verhoeven; RiLee Robeson; Rhett M Schiffman; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4111.

ARVO Annual Meeting Abstract September 2016

Extended Release of anti-VEGF Biologics from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration

Gary Owens; Melissa Sandahl; Melissa Hernandez; Andres Garcia; Stuart Williams; Tomas Navratil; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):527.

ARVO Annual Meeting Abstract September 2016

Completed 28-Day and Ongoing 12-Month Safety and Efficacy Evaluation of ENV515 (travoprost) Intracameral Implant in Phase 2 Study

Thomas R Walters; Tomas Navratil; Stacey Pittman; Virginia Conley; Leo Trevino; Bruce E Silverstein; Michael Depenbusch; Steven L Mansberger; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3025.

ARVO Annual Meeting Abstract September 2016

Precision Size and Shape Extended Release Intravitreal Dexamethasone Implants

Sanjib Kiumar Das; Stuart Williams; Janet Tully; Rozemarijn S Verhoeven; Mari Yang; Tomas Navratil; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3278.

ARVO Annual Meeting Abstract September 2016

In vitro and In vivo Sustained Release of Dexamethasone from a PRINT Microparticle Suspension

Melissa Sandahl; Melissa Hernandez; Janet Tully; Gary owens; Rozemarijn S Verhoeven; RiLee Robeson; Stuart Williams; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4023.

ARVO Annual Meeting Abstract September 2016

Sustained Release Biodegradable Formulations for Intraocular Delivery: Extended Release of Hydrophilic APIs and Combination Products

Janet Tully; Mari Yang; Melissa Sandahl; Stuart Williams; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4029.

ARVO Annual Meeting Abstract September 2016

Design and Development of ENV515 Intraocular Applicator for Intracameral Injections of ENV515 Glaucoma Extended Release (XR) Therapy

Tomas Navratil; Jessie Delgado; Andres Garcia; Gretchen Willard; Andrew Corson; Rozemarijn S Verhoeven; Leo Trevino; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3021.

ARVO Annual Meeting Abstract September 2016

A 6-Week Toxicity and Toxicokinetics Study of a Single Bilateral Intracameral Administration of ENV905 (difluprednate) Ophthalmic Implant in New Zealand White Rabbits

RiLee Robeson; Rozemarijn S Verhoeven; Andres Garcia; Paul Miller; Jacqueline Miller; Tomas Navratil; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4013.

ARVO Annual Meeting Abstract September 2016

A 6-Week Ocular Pharmacokinetic Study of ENV905 (difluprednate) Intracameral Implant or Durezol in the Albino Rabbit

Rozemarijn S Verhoeven; RiLee Robeson; Andres Garcia; Brian C Gilger; David Culp; Craig B Struble; Lee Hamm; Thomas Grizzle; Tomas Navratil; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5711.

ARVO Annual Meeting Abstract June 2015

Interim Results of a Dose Escalation Study of NT-503 Encapsulated Cell Therapy for the Treatment of Choroidal Neovascularization in AMD

Anat Loewenstein; Hugo Quiroz-Mercado; Jose Luis Guerrero-Naranjo; Sergio Rojas; Arturo Santos; Juan Carlos Altamirano; Yael Morales; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2277.

ARVO Annual Meeting Abstract June 2015

Proteomic Mass Spectroscopy Profiling of Proteins Secreted from an Encapsulated Cell Technology (ECT) Implant Device

Lisa D. Orecchio; Michael Rivera; Edward Brissette; Cahil McGovern; Arne Nystuen; Rhett Schiffman; Konrad Kauper

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):229.

ARVO Annual Meeting Abstract June 2015

Evaluation of Retinal Structure and Function of Rabbits Following Continuous VEGF Inhibition by Encapsulated Cell Therapy (ECT)

Alline M. A. Lelis; Michael Rivera; Lisa D. Orecchio; Pam Heatherton; Edward Brissette; Alice Lee; Cahil McGovern; Arne Nystuen; Rhett M Schiffman; Konrad Kauper

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):232.

1 2

Next 20 Results »

Advertisement